03:29 AM EDT, 09/08/2025 (MT Newswires) -- Jennifer L Taubert, Executive Vice President and Worldwide Chairman, Innovative Medicine, on September 04, 2025, sold 56,471 shares in Johnson & Johnson ( JNJ ) for $10,040,883. Following the Form 4 filing with the SEC, Taubert has control over a total of 178,013 common shares of the company, with 178,013 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml